Representative image | Photo Credit: Getty images The European Union’s drugs regulator on Thursday (November 14, 2024) recommended approval of Eisai and Biogen’s Leqembi for some patients with early ...
Boston: An injected version of Eisai and Biogen's Alzheimer's drug Leqembi works as well as the current intravenous administration at removing toxic brain plaques, but rates of serious side ...